Many studies have confirmed that CCN2 has a higher level of expression in lung cancer [5], pancreatic cancer [6], breast cancer [7], chondrosarcoma [8], and melanomas [9] than in normal tissues. This evidence concerns the gene CCN2 and breast carcinoma.